All products / DC21801
CAT. NO. DC21801
VU0155069
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $350 USDRequest a quote / confirm availability → |
| 250 mg | $700 USDRequest a quote / confirm availability → |
| 1 g | $1,400 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
VU0155069 is a potent, selective phospholipase D1 (PLD1) inhibitor with IC50 of 46 nM, 20-fold selectivity over PLD2 (IC50=933 nM); sensitizes MCF7 and MDA-MB-231 breast cancer cells to doxorubicin-induced cytotoxicity, suppresses growth of colorectal cancer activated by the Wnt/β-catenin and PI3K signaling pathways.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC21801 |
|---|---|
| Product name | VU0155069 |
| CAS | 1130067-06-9 |
| Molecular formula | C26H27ClN4O2 |
| Molecular weight | 462.971184968948 |
| Purity | >98% |
| SMILES | C[C@@H](CN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)NC(=O)c1ccc2ccccc2c1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — VU0155069 (DC21801)